ADH-10001

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameADH-10001
Drug Alias NameExherinADH-10001ADH-100001ADH-1
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAngiogenesis inhibitors
TargetsCadherin-2
Therapy Area/IndicationsPancreatic NeoplasmsGallbladder NeoplasmsDigestive System Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesItaly +[4] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMcgill - Queen'S University Press
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdherex Technologies IncUniversity of Nebraska
Active IndicationsN/A
Inactive IndicationsPancreatic NeoplasmsGallbladder NeoplasmsDigestive System Neoplasms +[8] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank